Human Molecular Genetics Advance Access originally published online on November 21, 2005
Human Molecular Genetics 2006 15(1):11-21; doi:10.1093/hmg/ddi421
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors
1Department of Medicine, Division of Nephrology 2Department of Oncology, Division of Biostatistics, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Building 9S., Baltimore, MD 21205, USA
* To whom correspondence should be addressed. Tel: +1 4106140089; Fax: +1 4106145129; Email: ggermino{at}jhmi.edu
Received September 26, 2005; Accepted November 7, 2005
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations of PKD1 and PKD2. Murine gene targeting studies have shown that these genes play an essential role in development, with homozygous inactivation resulting in embryonic lethality. Recently, Pkd1/ lethality has been linked to placental insufficiency. In this study, the placenta was used as a model to identify factors involved in these developmental abnormalities. Microarray analysis of Pkd1/ placentae showed upregulation of a set of apolipoprotein-related genes. These changes were validated and were found to be associated with increased quantities of apolipoproteins in the amniotic fluid. Increased apolipoprotein gene expression was also observed in Pkd2/placentae and in cystic kidneys of Pkd1cond/; Meox2cre/+ mice. Using chromatin immunoprecipitation assays, we determined that the activity of HNF-4
, a major regulator of apolipoprotein gene expression, was also increased in these organs. These findings suggest a potential role for dysregulation of nuclear hormone receptors in the pathogenesis of ADPKD.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. P. Calvet Strategies to Inhibit Cyst Formation in ADPKD Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1205 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Lantinga-van Leeuwen, W. N. Leonhard, A. van der Wal, M. H. Breuning, E. de Heer, and D. J.M. Peters Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice Hum. Mol. Genet., December 15, 2007; 16(24): 3188 - 3196. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Weimbs Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1 Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1423 - F1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Magenheimer, P. L. St. John, K. S. Isom, D. R. Abrahamson, R. C. De Lisle, D. P. Wallace, R. L. Maser, J. J. Grantham, and J. P. Calvet Early Embryonic Renal Tubules of Wild-Type and Polycystic Kidney Disease Kidneys Respond to cAMP Stimulation with Cystic Fibrosis Transmembrane Conductance Regulator/Na+,K+,2Cl- Co-Transporter-Dependent Cystic Dilation J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3424 - 3437. [Abstract] [Full Text] [PDF] |
||||



